Ghanem E. Ghanem

971 total citations
25 papers, 528 citations indexed

About

Ghanem E. Ghanem is a scholar working on Oncology, Molecular Biology and Cell Biology. According to data from OpenAlex, Ghanem E. Ghanem has authored 25 papers receiving a total of 528 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 15 papers in Molecular Biology and 6 papers in Cell Biology. Recurrent topics in Ghanem E. Ghanem's work include Melanoma and MAPK Pathways (9 papers), Cutaneous Melanoma Detection and Management (6 papers) and melanin and skin pigmentation (5 papers). Ghanem E. Ghanem is often cited by papers focused on Melanoma and MAPK Pathways (9 papers), Cutaneous Melanoma Detection and Management (6 papers) and melanin and skin pigmentation (5 papers). Ghanem E. Ghanem collaborates with scholars based in Belgium, France and United Kingdom. Ghanem E. Ghanem's co-authors include Fabrice Journé, Mohammad Krayem, Ahmad Awada, Ahmad Najem, Sven Saussez, Renato Morandini, Dirk Van Gestel, Philippe Martinive, Rédouane Rouas and Marika Szabo and has published in prestigious journals such as Cancer Research, International Journal of Molecular Sciences and Journal of Investigative Dermatology.

In The Last Decade

Ghanem E. Ghanem

24 papers receiving 522 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ghanem E. Ghanem Belgium 12 284 223 103 84 61 25 528
Florian Rouaud Switzerland 14 394 1.4× 139 0.6× 142 1.4× 78 0.9× 100 1.6× 19 630
Rebecca S. Dise United States 8 338 1.2× 124 0.6× 123 1.2× 77 0.9× 67 1.1× 9 600
Anthony L. Sinn United States 14 373 1.3× 223 1.0× 55 0.5× 139 1.7× 123 2.0× 35 699
Lucas B. Murray United States 7 770 2.7× 232 1.0× 100 1.0× 72 0.9× 83 1.4× 7 946
Cristina Casalou Portugal 13 313 1.1× 128 0.6× 132 1.3× 77 0.9× 69 1.1× 21 537
Philippe Depeille United States 13 437 1.5× 162 0.7× 53 0.5× 108 1.3× 73 1.2× 15 616
Marie‐Josée Langlois Canada 10 283 1.0× 103 0.5× 62 0.6× 63 0.8× 85 1.4× 17 461
Jessica Charlet United States 10 543 1.9× 86 0.4× 118 1.1× 60 0.7× 91 1.5× 14 742
Teng Ji China 16 347 1.2× 190 0.9× 62 0.6× 86 1.0× 99 1.6× 29 642
Longyue L. Cao United States 9 420 1.5× 211 0.9× 48 0.5× 97 1.2× 82 1.3× 9 614

Countries citing papers authored by Ghanem E. Ghanem

Since Specialization
Citations

This map shows the geographic impact of Ghanem E. Ghanem's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ghanem E. Ghanem with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ghanem E. Ghanem more than expected).

Fields of papers citing papers by Ghanem E. Ghanem

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ghanem E. Ghanem. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ghanem E. Ghanem. The network helps show where Ghanem E. Ghanem may publish in the future.

Co-authorship network of co-authors of Ghanem E. Ghanem

This figure shows the co-authorship network connecting the top 25 collaborators of Ghanem E. Ghanem. A scholar is included among the top collaborators of Ghanem E. Ghanem based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ghanem E. Ghanem. Ghanem E. Ghanem is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Najem, Ahmad, Mohammad Krayem, Fabrice Journé, et al.. (2023). Targeting Prohibitins to Inhibit Melanoma Growth and Overcome Resistance to Targeted Therapies. Cells. 12(14). 1855–1855. 5 indexed citations
2.
3.
Najem, Ahmad, Fabrice Journé, Ahmad Awada, et al.. (2023). The benefit of co-targeting PARP-1 and c-Met on the efficacy of radiotherapy in wild type BRAF melanoma. Frontiers in Medicine. 10. 1149918–1149918. 4 indexed citations
4.
Penninckx, Sébastien, et al.. (2022). Understanding the Radiobiological Mechanisms Induced by 177Lu-DOTATATE in Comparison to External Beam Radiation Therapy. International Journal of Molecular Sciences. 23(20). 12369–12369. 10 indexed citations
5.
Abou‐Hamdan, Hussein, Hajime Yurugi, Ahmad Najem, et al.. (2022). Development of fluorizoline analogues as prohibitin ligands that modulate C-RAF signaling, p21 expression and melanogenesis. European Journal of Medicinal Chemistry. 242. 114635–114635. 3 indexed citations
6.
Ghanem, Ghanem E., et al.. (2022). Bufalin for an innovative therapeutic approach against cancer. Pharmacological Research. 184. 106442–106442. 68 indexed citations
7.
Najem, Ahmad, Jasper Wouters, Mohammad Krayem, et al.. (2021). Tyrosine-Dependent Phenotype Switching Occurs Early in Many Primary Melanoma Cultures Limiting Their Translational Value. Frontiers in Oncology. 11. 780654–780654. 8 indexed citations
8.
Rouas, Rédouane, Ghanem E. Ghanem, Philippe Martinive, et al.. (2021). Humanized Mice as a Valuable Pre-Clinical Model for Cancer Immunotherapy Research. Frontiers in Oncology. 11. 784947–784947. 70 indexed citations
9.
Ghanem, Ghanem E., et al.. (2021). Investigating intrinsic radiosensitivity biomarkers to peptide receptor radionuclide therapy with [177Lu]Lu-DOTATATE in a panel of cancer cell lines. Nuclear Medicine and Biology. 96-97. 68–79. 6 indexed citations
10.
Krayem, Mohammad, Nadège Kindt, Ahmad Najem, et al.. (2021). Abstract 1082: Regorafenib resistance is associated with senescence-like phenotype and EMT in colorectal cancer (CRC). Cancer Research. 81(13_Supplement). 1082–1082. 1 indexed citations
11.
Najem, Ahmad, et al.. (2021). RTK Inhibitors in Melanoma: From Bench to Bedside. Cancers. 13(7). 1685–1685. 31 indexed citations
12.
Krayem, Mohammad, Ahmad Najem, Ghanem E. Ghanem, et al.. (2020). Metabolic Reprogramming in Metastatic Melanoma with Acquired Resistance to Targeted Therapies: Integrative Metabolomic and Proteomic Analysis. Cancers. 12(5). 1323–1323. 16 indexed citations
13.
Krayem, Mohammad, Ahmad Najem, Thierry Cresteil, et al.. (2018). Targeting prohibitin with small molecules to promote melanogenesis and apoptosis in melanoma cells. European Journal of Medicinal Chemistry. 155. 880–888. 31 indexed citations
14.
Najem, Ahmad, Mohammad Krayem, François Salès, et al.. (2017). P53 and MITF/Bcl-2 identified as key pathways in the acquired resistance of NRAS-mutant melanoma to MEK inhibition. European Journal of Cancer. 83. 154–165. 41 indexed citations
15.
Lejeune, Ferdy J., et al.. (2015). An Accurate Method for Cytostatic Dosimetry in Isolation Perfusion Based on Limb Vascular Volume Determination. Antibiotics and chemotherapy/Antibiotica et chemotherapia. 40. 63–76.
16.
Anghel, Silvia I., Eva Budínská, Kayluz Frias Boligan, et al.. (2012). Breast cancer suppressor candidate‐1 (BCSC‐1) is a melanoma tumor suppressor that down regulates MITF. Pigment Cell & Melanoma Research. 25(4). 482–487. 17 indexed citations
17.
Dessars, Barbara, Renato Morandini, Anne Lefort, et al.. (2008). Genotypic and Gene Expression Studies in Congenital Melanocytic Nevi: Insight into Initial Steps of Melanotumorigenesis. Journal of Investigative Dermatology. 129(1). 139–147. 43 indexed citations
18.
19.
Dessars, Barbara, Hakim El Housni, Renato Morandini, et al.. (2007). Chromosomal Translocations as a Mechanism of BRAF Activation in Two Cases of Large Congenital Melanocytic Nevi. Journal of Investigative Dermatology. 127(6). 1468–1470. 54 indexed citations
20.
Moustafa, Manar, E. Helen Kemp, Marika Szabo, et al.. (2002). Inhibition of Tumor Necrosis Factor-α Stimulated NFκB/p65 in Human Keratinocytes by α-Melanocyte Stimulating Hormone and Adrenocorticotropic Hormone Peptides. Journal of Investigative Dermatology. 119(6). 1244–1253. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Florian Rouaud Breakdown of academic impact, for papers by Rebecca S. Dise Breakdown of academic impact, for papers by Anthony L. Sinn Breakdown of academic impact, for papers by Lucas B. Murray Breakdown of academic impact, for papers by Cristina Casalou Breakdown of academic impact, for papers by Philippe Depeille Breakdown of academic impact, for papers by Marie‐Josée Langlois Breakdown of academic impact, for papers by Jessica Charlet Breakdown of academic impact, for papers by Teng Ji Breakdown of academic impact, for papers by Longyue L. Cao
Rankless by CCL
2026